Main takeaway: The company will review the resumption of dividends in FY26, after they were suspended in February following its $902m capital raise.
Ryman Healthcare has kicked the can down the road on the potential resumption of dividends by two years.
The company suspended making distributions to shareholders followings its $902 million capital raise in February, saying it was not suitable to raise money on one hand and give it back with
